NOVO NORDISK'S RETATRUTIDE: THE NEW APPROACH FOR WEIGHT LOSS?

New clinical evidence suggests that Novera Retatrutide, a twin-action medication from Novo Nordisk, could offer a significant breakthrough in weight control. Beyond many existing options, Retatrutide impacts both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GI